Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aileron Therapeutics Inc (NQ: ALRN ) 4.000 -0.120 (-2.91%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Aileron Therapeutics Inc < Previous 1 2 3 Next > ALRN Stock Earnings: Aileron Therapeutics Misses EPS for Q2 2024 August 15, 2024 ALRN stock results show that Aileron Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace ALRN Stock Earnings: Aileron Therapeutics Reported Results for Q1 2024 May 15, 2024 Aileron Therapeutics just reported results for the first quarter of 2024. Via InvestorPlace Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights May 15, 2024 From Aileron Therapeutics, Inc. Via GlobeNewswire Aileron Therapeutics to Present at Two Upcoming Investor Conferences May 06, 2024 From Aileron Therapeutics, Inc. Via GlobeNewswire BioMedNewsBreaks — Aileron Therapeutics Inc. (NASDAQ: ALRN) Closes Underwritten Registered Direct Offering May 06, 2024 Via Investor Brand Network Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million May 03, 2024 Includes initial funding of approximately $20 million, as well as the potential for additional proceeds of approximately $20 million from exercise of three-year warrants issued in offering From Aileron Therapeutics, Inc. Via GlobeNewswire Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million May 01, 2024 Includes initial funding of approximately $20 million, as well as the potential for additional proceeds of approximately $20 million from exercise of three-year warrants issued in offering From Aileron Therapeutics, Inc. Via GlobeNewswire Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) May 01, 2024 From Aileron Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session April 18, 2024 Via Benzinga Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 18, 2024 Via Benzinga Aileron Therapeutics Inc. (NASDAQ: ALRN) Leading the Way in Thursday Trading Based on Percentage Gain April 18, 2024 Via Investor Brand Network ALRN Stock Earnings: Aileron Therapeutics Reported Results for Q4 2023 April 16, 2024 Aileron Therapeutics just reported results for the fourth quarter of 2023. Via InvestorPlace Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update April 15, 2024 From Aileron Therapeutics, Inc. Via GlobeNewswire Aileron Therapeutics Announces CEO Transition March 12, 2024 From Aileron Therapeutics, Inc. Via GlobeNewswire Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event February 15, 2024 Topline results from Phase 1b study of LTI-03, Aileron’s novel Caveolin-1-related peptide in development for the treatment of idiopathic pulmonary fibrosis, expected in the second quarter of 2024 From Aileron Therapeutics, Inc. Via GlobeNewswire Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024 February 01, 2024 Panel discussion will highlight LTI-03, Aileron’s novel Caveolin-1-related peptide, for the treatment of idiopathic pulmonary fibrosis From Aileron Therapeutics, Inc. Via GlobeNewswire Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session January 30, 2024 Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session January 23, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session January 12, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday January 12, 2024 We're starting out the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning! Via InvestorPlace Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session December 15, 2023 Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter financial results. Quanex Building Products shares fell 10.7% to... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session December 15, 2023 Via Benzinga Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket December 15, 2023 Shares of Getaround, Inc. (NYSE: GETR) rose sharply in pre-market trading after the company reported a year-over-year increase in third-quarter financial results. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session December 15, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday December 15, 2023 It's time to dive into the biggest pre-market stock movers for Friday morning as we check out the winners and losers today! Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session December 14, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session November 06, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session November 01, 2023 Via Benzinga Top 5 Health Care Stocks That May Collapse In Q2 May 10, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga Stocks That Hit 52-Week Lows On Monday April 03, 2023 On Monday, 76 companies set new 52-week lows. Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
